CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
that suggests the potential for clinical benefit of COVID-19 patients with controlled cancers.1. Treat Infection of Multiple Gene M-...
Early Phase 1
North Bethesda, Maryland, United States
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Silver Spring, Maryland, United States and 11 other locations
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...
Phase 2
Washington, District of Columbia, United States and 54 other locations
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...
Baltimore, Maryland, United States
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Millersville, Maryland, United States and 6 other locations
mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...
Phase 1
Baltimore, Maryland, United States and 2 other locations
This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...
Phase 2
Baltimore, Maryland, United States and 5 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Washington, District of Columbia, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Baltimore, Maryland, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Washington, District of Columbia, United States and 89 other locations
Clinical trials
Research sites
Resources
Legal